Check the approved drug approval number in the last 8 days of 2014

As of January 22, 2015, according to the tracking of national CFDA approval documents by Xianda data 3.0, in the last eight days of December 2014, CFDA approved a total of 52 drug approval documents, of which 49 were approved on December 23, considering that CFDA and CDE also competed in the last few days The result of over exertion will be a little bug For example, the registration progress of cyhs0990025 in SFDA shows that it is "under review" In fact, it was approved for production at the end of last year (gyzzh20143390) Why does this paradox occur? Through the detailed progress page of Xianda data, we finally see the reason (Figure 1) Fig 1 SFDA processing status change history of flupentixicine tablets (Xianda data scan and record the processing status of acceptance number every day) The variety was approved on December 24, 2014, and the approval document was sent to the manufacturer on January 7, 2015 Then a miracle occurred, and the processing status became "under review", and the status time was March 7, 2006, but the variety was not accepted at that time!!! Therefore, don't be superstitious about the real-time progress through software query In this unreliable era, "real-time" seems to be unreliable As shown in Table 1, the approval documents approved in the last 8 days have been put on the market for the first time, and some have broken the current exclusive specifications and exclusive dosage forms of some products Considering that the bidding year of 2014 has not been released yet, we all hope that the bidding year of 2015 can be realized, and we can understand your efforts CFDA's approval process has been significantly accelerated, and it is visually observed that the exclusive pattern of some generic products caused by "slow approval" will be gradually broken Affected by this, the price war of generic drugs is expected to be staged one after another, and then there is a story of political achievements of bidding to reduce drug prices Are you ready for the era of generic wars?